Samuel Lawrie Drew

Title: Innovations of Samuel Lawrie Drew

Introduction

Samuel Lawrie Drew is a notable inventor based in Millbrae, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of seven patents to his name, Drew's work has the potential to impact various medical treatments.

Latest Patents

Drew's latest patents include the development of 2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds. These compounds are designed to inhibit PI3Kγ and are described in detail along with their compositions and methods for synthesis. The applications of these compounds extend to the treatment of a diverse array of diseases, including cancer and immune-related disorders that are mediated by PI3Kγ. Another significant patent involves a process for preparing tetralin compounds, which outlines methods and intermediates useful for synthesizing these compounds at multigram or kilogram scales.

Career Highlights

Samuel Lawrie Drew is currently associated with Arcus Biosciences, Inc., where he continues to innovate in the field of drug development. His expertise and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Drew has collaborated with notable colleagues such as Joel Worley Beatty and Kenneth Victor Lawson. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Samuel Lawrie Drew's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to lead to significant breakthroughs in the treatment of various diseases.